Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06197425 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer

Study acronym: CIRCULATE PAC
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Primary and study completion dates: Jan 2030 to May 2032 · Start date changed from estimate of Jan 2024 to May 7, 2026 · Site details revisedv2 Show 3 more changesShow less
    • Primary and study completion dates: Jan 2030 to May 2032
    • Start date changed from estimate of Jan 2024 to May 7, 2026
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Phase III multicentric, open-label, randomized study The main objective is to assess the efficacy on time to disease recurrence (TTR) of treating minimal residual disease diagnosed by the presence of ctDNA after full treatment (surgery + chemotherapy) in stage III or high-risk stage II colon or upper rectum adenocarcinoma
Trial Details
NCT Number NCT06197425
Lead Sponsor Centre Hospitalier Universitaire Dijon
Conditions Colon or Upper Rectum Adenocarcinoma
Enrollment 1,660 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov